In this episode of Demystifying Cosmetics, Jennifer speaks with Gloria Lu, cosmetic chemist and co-founder of Chemist Confessions, about how skincare ingredient trends actually move through the beauty industry, and why some ingredients keep resurfacing while others burn hot and fade fast. From niacinamide and hyaluronic acid to peptides, ceramides, bakuchiol, growth factors, and exosomes, they unpack what separates real topical potential from hype-driven storytelling.
The conversation explores why ingredient cycles often begin in adjacent categories like therapeutics or in-office aesthetics before entering skincare, how early mechanistic data gets overstretched in marketing, and what brands and consumers should really look for when deciding whether a trending ingredient is worth attention. Gloria also breaks down the difference between in vitro promise and topical in vivo proof, why peptide marketing has become so murky, and how consumer expectations should be balanced against actual evidence.

Learn more at https://chemistconfessions.com/

Takeaways:
• Ingredient Trends Often Start Outside Topical Skincare: Gloria explains how many skincare trends begin in adjacent spaces like medicine, therapeutics, supplements, or aesthetics before migrating into topical beauty.
• Niacinamide and Hyaluronic Acid Keep Returning Because the Story Is Flexible: Some ingredients survive trend cycles because they are easy to formulate, easy to communicate, and can attach themselves to multiple consumer concerns.
• Peptides Are Legitimate but Increasingly Difficult to Decode: While some peptides have real scientific backing, the category has become so broad and commercialized that both consumers and chemists have to look much closer at the actual material, sourcing, and studies.
• In Vitro Data Is Not Enough for Strong Topical Claims: One of the clearest points in the episode is that early-stage mechanistic or cell-culture testing should not be mistaken for meaningful proof of topical skincare performance.
• Ceramides Became Easier to Market Once Formulation Barriers Fell: The episode explores how improved supplier systems, blends, and lower formulation barriers helped ceramides move from technically valuable to commercially mainstream.
• Exosomes and Growth Factors Sit at the Edge of Science, Hype, and Consumer Fascination: Jennifer and Gloria discuss why regenerative-sounding categories remain commercially attractive even when the evidence, regulation, and consumer understanding are still evolving.
• Consumers Need a Better Framework for Vetting New Ingredients: Gloria closes the episode with a practical way to assess trending ingredients by looking for topical in vivo testing, realistic use conditions, and a clear reason to believe.

Timestamps:
00:00 Cold Open
00:47 Start
01:16 Meet Gloria Lu
02:18 How Ingredient Trends Move Through Beauty
03:34 CBD and the Gap Between Hype and Data
04:30 Why Niacinamide Keeps Coming Back
04:51 Hyaluronic Acid and Repeat Trend Cycles
05:53 Why Some Ingredients Are More Resilient
07:24 Peptides as a Legitimate but Over-Marketed Category
10:18 What Data Makes a Peptide Credible
11:57 What Consumers Should Look for in Finished Product Testing
13:22 Revisiting CBD as a Market Experiment
13:51 Are Peptides Following the Same Pattern?
15:34 [AD BREAK]
16:43 Ceramides and Why They Took So Long to Explode
20:16 Bakuchiol as a Retinol Alternative
23:19 Prescription Retinoids vs Cosmetic Retinoids
26:05 Why Growth Factors Never Really Go Away
30:48 Exosomes and the Current Stage of the Hype Cycle
33:45 A Simple Framework for Evaluating Trending Ingredients
34:02 Look for Topical In Vivo Data
35:09 Check Use Levels and Realistic Usage Conditions
36:14 Feel-Good Products vs Workhorse Products
37:22 Consumers, Expectations, and Ingredient Reality
38:09 Conclusion